Standout Papers

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year fo... 2014 2026 2018 2022 707
  1. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial (2014)
    Sung Hoon Noh, Sook Ryun Park et al. The Lancet Oncology

Immediate Impact

1 by Nobel laureates 59 standout
Sub-graph 1 of 22

Citing Papers

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
Mitochondrial Glutathione in Cellular Redox Homeostasis and Disease Manifestation
2024 Standout
4 intermediate papers

Works of Jong Inn Lee being referenced

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
2014 Standout

Author Peers

Author Last Decade Papers Cites
Jong Inn Lee 333 659 232 279 11 827
Kevin Raymond 256 696 298 203 15 853
Paul Nyandoto 290 747 577 180 13 985
Noboru Yamamichi 291 429 415 181 20 712
Robin S. Macherey 323 618 221 155 14 961
Miriam E. Vincent 780 495 162 249 15 970
A. Azzedine 227 419 726 85 8 965
Thomas d’Amato 207 574 195 76 19 865
Claire Saffery 325 614 555 197 17 860
M. Ebert 106 267 322 70 16 709
F Hofbauer 233 275 452 82 22 830

All Works

Loading papers...

Rankless by CCL
2026